Clinical Trial Update: Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial compared 0.5% ivermectin cream to placebo in individuals with head lice. The study has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head Lice

Drugs mentioned

• Ivermectin cream 0.5% (ivermectin)

Snippet

Sponsor: Topaz Pharmaceuticals Inc | Conditions: Head Lice | Phase 2 | Status: COMPLETED | Results posted: 2012-04-04